Formulary
Lenvatinib [Specialist drug]: Indications, Dosing, Side Effects and Interactions
Lenvatinib [Specialist drug] clinical drug profile including indications, dosing, side effects, cautions and interactions.
MedNext Academy | 3 min read
Lenvatinib [Specialist drug]: Indications, Dosing, Side Effects and Interactions
Lenvatinib [Specialist drug] clinical drug profile including indications, dosing, side effects, cautions and interactions.
Indications and dose
**Renal cell carcinoma**
- **Adult** (By Mouth): Specialist drug - access specialist resources for dosing information.
**Differentiated thyroid carcinoma,Hepatocellular carcinoma,Endometrial carcinoma**
- **Adult** (By Mouth): Specialist drug - access specialist resources for dosing information.
Contraindications
For lenvatinib [Specialist drug] Fistulae
Side effects
For lenvatinib [Specialist drug] Common or very common Alopecia; appetite decreased; arthralgia; asthenia; cerebrovascular insufficiency; cholecystitis; constipation; decreased leucocytes; dehydration; diarrhoea; dizziness; dry mouth; dysphonia; electrolyte imbalance; embolism and thrombosis; encephalopathy; gastrointestinal discomfort; gastrointestinal disorders; haemorrhage; headache; heart failure; hepatic coma; hepatic disorders; hyperbilirubinaemia; hypercholesterolaemia; hypertension; hypoalbuminaemia; hypotension; hypothyroidism; increased risk of infection; insomnia; malaise; mucositis; myalgia; myocardial infarction; nausea; neutropenia; oral disorders; oropharyngeal complaints; pain; peripheral oedema; proteinuria; QT interval prolongation; renal impairment; renal tubular necrosis; skin reactions; taste altered; thrombocytopenia; vomiting; weight decreased Uncommon Adrenal insufficiency; healing impaired; nephrotic syndrome; osteonecrosis of jaw; pancreatitis; paresis; pneumothorax; splenic infarction Frequency not known Aneurysm; anxiety; artery dissection; cardiac disorder; cardiogenic shock; fistula; intracranial haemorrhage; neoplasm complications Side-effects, further information Manufacturer advises gastrointestinal toxicity should be actively managed - dehydration and/or hypovolaemia caused by gastrointestinal toxicity are identified as primary risk factors for renal impairment or failure.
Medicinal forms
Clinical governance
**Author:** MedNext Clinical Team. **Clinical reviewer:** Dr Shameer Deen, MBBS, MS, MRCS. **Sources:** BNF, Indian Pharmacopoeia, CIMS India. **Correction:** Report errors at support@mednext.academy.
Inside MedNext for this topic
- 411 MedNext-authored chapters
- 80,000+ MCQ bank
- 15 study modes
- Growing visual cheat sheets
Study modes
- Notes
- MCQ
- Audio
- Video
- Visual
- 3D Anatomy
- Trace
- Flashcards
- Mnemonics
- Image Bank
- Clinical
- Microscopy
- Audio QBank
- Cadaver
- Book Match
Continue reading
Subject HubPharmacology Hub
All pharmacology resources in one place.
Drug SchedulesIndian Drug Schedules
Schedule H, H1, X and G classifications.
FormularyBrowse all drugs
Search 1,850+ drug profiles.
Study Lenvatinib [Specialist drug] in the MedNext app
Challenge yourself with targeted pharmacology MCQs on this drug class. Every explanation links back to the chapter that teaches the concept.
Start drug challengeExplore the full formulary

